ARTICLE | Company News
Novartis, UPenn get breakthrough for CAR therapy
July 7, 2014 11:41 PM UTC
Novartis AG (NYSE:NVS; SIX:NOVN) and partner University of Pennsylvania said FDA granted breakthrough therapy designation for CTL019 to treat relapsed/refractory adult and pediatric acute lymphoblasti...